Published
The Advanced Research Projects Agency for Health (ARPA-H) announced Dr. Rafid Fadul as its inaugural Chief Medical Officer (CMO). In this capacity, Dr. Fadul will work to ensure that all of ARPA-H's groundbreaking innovations have a meaningful impact for patients, providers, and payers. ARPA-H believes the most powerful health innovations occur at the intersections—where engineering meets medicine, where prevention meets treatment, where artificial intelligence meets drug discovery. The role of Chief Medical Officer will serve as a critical bridge between frontier science and frontline care.
“I joined ARPA-H because it’s the country’s premier engine for frontier-shattering breakthroughs in health and biotech,” said Fadul. “I’ve dedicated my career to leveraging innovation to save and improve lives. At ARPA-H, I get to do that at a truly national scale, and I couldn’t be more excited.”
Dr. Fadul brings a unique combination of clinical expertise and healthcare innovation leadership to his role as ARPA-H's CMO. After transitioning from bedside practice to healthcare technology entrepreneurship, he has spent the past decade building and scaling companies at the intersection of clinical care delivery and digital health solutions.
Dr. Fadul joins ARPA-H from Zivian Health, a company he co-founded and led in developing comprehensive healthcare software platforms serving medical providers nationwide, addressing challenges in regulatory compliance, clinical workflow optimization, and data interoperability. Concurrently, Dr. Fadul served as Chief Medical Advisor at Cenegenics, where he oversaw clinical programs in longevity medicine and emerging therapeutics, maintaining direct connection to evolving patient care needs and clinical practice realities.
Dr. Fadul is board-certified in internal medicine, pulmonary disease, and critical care medicine and holds an M.D. from the George Washington University, as well as an MBA from Johns Hopkins University.